Fermenta Biotech Ltd. Investor Presentation

Fermenta Biotech Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more

announcement
Conference/Earnings Calls Alerts
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Further to our intimation dated November 11, 2022 regarding approval of Unaudited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and half year ended September 30, 2022, we hereby enclose a copy of Earnings Presentation for Quarter 2 / Half Year 1 - Financial Year 2022-2023. The said Earnings Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby enclose a copy of Investor Presentation for September 2022 for your information. The said Investor Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly take the same on records.
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Further to our intimation dated August 12, 2022 regarding approval of Unaudited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter ended June 30, 2022, we hereby enclose a copy of Earnings Presentation for Quarter 1 - Financial Year 2022-2023. The said Earnings Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Intimation of Investor Presentation - June 2022 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby enclose a copy of Investor Presentation for June 2022 for your information. The said Investor Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly take the same on records.
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Corrigendum - Intimation of Earnings Presentation for Quarter 4 - Financial Year 2021-2022 [Q4-FY22/FY22] With reference to our intimation dated May 31, 2022 regarding Earnings Presentation for Quarter 4 - Financial Year 2021-2022, we hereby inform you that there was a typographical error on page 6 - para 2 'Q4-FY22 Operational Highlights' of the said Earnings Presentation. In view of above, we hereby enclose the revised Earnings Presentation for Quarter 4 - Financial Year 2021-2022 for your record. Except the said revision on page 6 - para 2 'Q4-FY22 Operational Highlights', all other details remain unchanged. The revised Earnings Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Intimation of Earnings Presentation for Quarter 4 - Financial Year 2021-2022 [Q4-FY22/FY22] Further to our intimation dated May 30, 2022 regarding approval of Audited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and financial year ended March 31, 2022, we hereby enclose a copy of Earnings Presentation for Quarter 4 - Financial Year 2021-2022. The said Earnings Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com Kindly take the same on record.
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby enclose a copy of Investor Relations Presentation for March 2022 for your information. The said Investor Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby enclose a copy of Investor Relations Presentation for February 2022 for your information. The said Investor Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Intimation of Earnings Presentation for 9 Months / Quarter 3 - Financial Year 2021-2022 Further to our intimation dated February 14, 2022, regarding approval of un-audited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and nine months ended December 31, 2021, we hereby enclose a copy of Earnings Presentation for 9 Months / Quarter 3 - Financial Year 2021-2022. The said Earnings Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com Kindly take the same on record.
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby enclose a copy of Investor Relations Presentation for December 2021 for your information. The said Investor Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.